Priya Sachdeva

Stock Analyst at UBS

(n/a)

# 4,777

Out of 4,944 analysts

5

Total ratings

n/a

Success rate

-17.92%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Priya Sachdeva

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	PEN Penumbra	Maintains: Buy	$330 → $335	$248.55	+34.78%	4	Jul 30, 2025
	NPCE NeuroPace	Initiates: Buy	$17	$9.13	+86.20%	1	Jan 21, 2025

Penumbra

Jul 30, 2025

Maintains: Buy

Price Target: $330 → $335

Current: $248.55

Upside: +34.78%

NeuroPace

Jan 21, 2025

Initiates: Buy

Price Target: $17

Current: $9.13

Upside: +86.20%